22nd January 2018
- 0 comments
AlzProtect, a biopharmaceutical company engaged in the development of drugs for the treatment of neurodegenerative diseases including Alzheimer's disease, announced 14 million euros in series B funding led by Xerys.
...Register / Login now to read full story
In order to read the full story we need you to be registered with us, please click the links below to login or register.
Back to Homepage